CS-57

Healing Rates of Foot Wounds Treated by a Composite Graft of Silicone and Bovine Tendon Collagen

Amanda Pajouh, Jennifer Kep, DPM – Fellow; Amanda Killeen, DPM; Javier La Fontaine, DPM, MS; Lawrence Lavery, DPM, MPH

Presented at Symposium on Advanced Wound Care Spring 2021

Objective: To assess healing rates of foot and ankle wounds treated with composite graft of silicone and bovine tendon collagen (CGSBTC) in patients with and without diabetes.

Methods: This is a retrospective study of lower extremity wounds treated with CGSBTC from 2017-2020 in 47 consecutive patients, with and without diabetes (83% and 17%, respectively). Diabetes was defined using American Diabetes Association criteria. Data was collected on demographics, comorbidities, follow-up time, time to heal, reinfections, readmission, and amputation level. Mean follow-up time was 26 weeks. We compared risk factors and outcomes in healers versus non-healers using T-test and Chi square.

Results: Thirty-one (66%) patients healed in 24.8615.21 weeks. There were 17 foot-related readmissions and 13 minor amputations after initial hospital discharge. Patients without diabetes healed in 21.83 14.77 weeks, and patients with diabetes healed in 25.5815.52 weeks.

Conclusion: At baseline, no demographic criteria or comorbidity showed a significant difference between the healers versus non-healer groups.

Trademark

Integra

Follow us on Twitter!

Meeting Highlights

Webinars

Proposed LCDs & LCAs for CTPs: NOW WHAT?

A New Paradigm Shift in Wound Care: Intimate Conversations about Missed Opportunities to Help Rethink What’s Possible with Early Initiation of Instillation Therapy and Beyond

Presented by: Luis G. Fernández, MD, KHS, KCOEG, FACS, FASAS, FCCP, FCCM, FICS; Paul J. Kim, DPM, MS, FACFAS; and Saeed A. Chowdhry, MD, FACS. It is known in the literature about the clinical and economic benefits of instillation therapy, ranging from reductions in hospital stays to fe...